Asenapine use while Breastfeeding
Drugs containing Asenapine: Saphris
Asenapine Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because there is no published experience with asenapine during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Possible Effects on Lactation
Asenapine has caused elevated prolactin serum in patients taking the drug.[1] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
References
1. Anon. Saphris package insert. Merck & Co., Inc. 2009.
Asenapine Identification
Substance Name
CAS Registry Number
65576-45-6
Drug Class
- Antipsychotic Agents
Administrative Information
LactMed Record Number
819
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
2010-12-07
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
See Also...
- Asenapine use during Pregnancy
- Asenapine Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy
Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.
